|
|
by Terasawa, Teruhiko, Dahabreh, Issa J., Castaldi, Peter J., Trikalinos, Thomas A.
Published 2010
Subjects:
“...Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy...”Published 2010
AHRQ Technology Assessment Program
|
|
by Terasawa, Teruhiko, Dahabreh, Issa J., Castaldi, Peter J., Trikalinos, Thomas A.
Published 2010
Subjects:
“...Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy...”Published 2010
AHRQ Technology Assessment Program
|
|
by Trikalinos, Thomas A.
Published 2012
“...--data from 7 cohorts, 123,122 participants), with no significant change in risk (positive or negative...”Published 2012
U.S. Department of Health and Human Services, Agency for Healthcare Research and Quality
|
|
by Trikalinos, Thomas A., Hoaglin, David C., Small, Kevin M., Schmid, Christopher H.
Published 2013
Published 2013
Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services
|
|
by Trikalinos, Thomas A., Hoaglin, David C., Small, Kevin M., Schmid, Christopher H.
Published 2013
Published 2013
Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services
|
|
by Dahabreh, Issa J.
Published 2012
Published 2012
Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services
|
|
by Dahabreh, Issa J.
Published 2012
Published 2012
Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services
|
|
by Clark, Alexander M., McAlister, Finlay, Hartling, Lisa, Vandermeer, Ben
Published 2005
Published 2005
Agency for Healthcare Research and Quality
|
|
by Clark, Alexander M., McAlister, Finlay, Hartling, Lisa, Vandermeer, Ben
Published 2005
Published 2005
Agency for Healthcare Research and Quality